Tower Research Capital (TRC)’s Bioceres Crop Solutions BIOX Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIOX Stock Details BIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34K	Buy	+9,547	New	+$4.49K	﹤0.01%	4547
2026 Q1	–	Sell	-410	Closed	-$537	–	5137
2025 Q4	$537	Sell	410 -922	-69%	-$1.48K	﹤0.01%	4878
2025 Q3	$1.88K	Sell	1,332 -3,924	-75%	-$12K	﹤0.01%	4717
2025 Q2	$23.5K	Buy	+5,256	New	+$23.7K	﹤0.01%	3591
2025 Q1	–	Sell	-539	Closed	-$3.28K	–	5208
2024 Q4	$3.28K	Sell	539 -2,617	-83%	-$17.9K	﹤0.01%	4678
2024 Q3	$24.8K	Buy	3,156 +2,484	+370%	+$25.1K	﹤0.01%	3113
2024 Q2	$7.53K	Sell	672 -830	-55%	-$9.7K	﹤0.01%	4456
2024 Q1	$19K	Buy	1,502 +479	+47%	+$6.31K	﹤0.01%	3048
2023 Q4	$14K	Buy	+1,023	New	+$12K	﹤0.01%	3912
2023 Q2	–	Sell	-403	Closed	-$5K	–	6041
2023 Q1	$5K	Sell	403 -724	-64%	-$8.52K	﹤0.01%	4932
2022 Q4	$14K	Buy	1,127 +185	+20%	+$2.4K	﹤0.01%	3490
2022 Q3	$12K	Buy	+942	New	+$11.6K	﹤0.01%	4324

Other funds holding BIOX

Solel Partners Boston, Massachusetts $588M AUM 14.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PCM

Ping Capital Management New York $401M AUM 32.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Tower Research Capital (TRC)'s BIOX Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Bioceres Crop Solutions (BIOX) in Q2 2026: 9,547 shares worth $3.34K. The stake represents ﹤0.01% of the portfolio and ranks #4547 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in BIOX as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in BIOX in Q3 2022 and has held it in 12 quarters since. The position peaked at $24.8K in Q3 2024. 28 funds tracked by Wall St. Rank hold BIOX as of Q2 2026.

Tower Research Capital (TRC) held 9,547 shares of Bioceres Crop Solutions worth $3.34K as of Q2 2026.
Bioceres Crop Solutions was a new Tower Research Capital (TRC) position in Q2 2026.
Bioceres Crop Solutions made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4547 holding.
Tower Research Capital (TRC) first reported a position in Bioceres Crop Solutions in Q3 2022 and has held it in 12 quarters since.
Tower Research Capital (TRC)'s Bioceres Crop Solutions position peaked at $24.8K in Q3 2024.
28 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.